Variability in the PR and RT genes of HIV-1 isolated from recently infected subjects

Antiviral Chemistry and Chemotherapy

Volumn 15, Issue 5, 2004, Pages 255-259

  Turner, Dan ^a   Roldan, Ariel ^a   Brenner, Bluma ^a   Moisi, Daniela ^a   Routy, Jean Pierre ^b   Wainberg, Mark A ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

HIV 1; pol gene; Variability

Indexed keywords

AMINO ACID SUBSTITUTION; ARTICLE; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MUTATION; PR GENE; PRIORITY JOURNAL; RT GENE; STRUCTURAL GENE; VIRUS GENE; VIRUS ISOLATION; VIRUS LOAD;

EID: 7544232753     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632020401500504     Document Type: Article

References (22)

1. Borrow P, Lewicki H, Hahn BH, Shaw GM & Oldstone MB (1994) Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. Journal of Virology 68:6103-6110.
2. Brenner B, Routy JP, Quan Y, Moisi D, Oliveira M, Turner D, Wainberg MA & co-investigators of the Quebec Primary Infection Study (2004) Persistence of multidrug-resistant HIV-1 in primary infection leading to superinfection. AIDS 18:1653-1660.
3. Brenner B, Turner D, Oliveira M, Moisi D, Detorio M, Carobene M, Marlink R-G, Schapiro J-M, Roger M & Wainberg MA (2003) A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors. AIDS 17:F1-5.
4. Hahn BH, Shaw GM, Taylor ME, Redfield RR, Markham PD, Salahuddin SZ, Wong-Staal F, Gallo RC, Parks ES & Parks WP (1986) Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS. Science 232:1548-1553.
5. Inouye P, Cherry E, Mayla H, Zolla-Pazner S & Wainberg MA (1998) Neutralizing antibodies directed against the V3 loop select for different escape variants in a virus with mutated reverse transcriptase (M184V) than in wild-type human immunodeficiency virus type 1. AIDS Research & Human Retroviruses 14:735-740.
6. Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, Borkowsky W, Farthing C & Ho DD (1994) Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. Journal of Virology 68:4650-4655.
7. Li WH, Tanimura M & Sharp PM (1988) Rates and dates of divergence between AIDS virus nucleotide sequences. Molecular Biology & Evolution 5:313-330.
8. Loemba H, Brenner B, Parniak MA, Maayan S, Spira B, Moisi D, Oliveira M, Detorio M & Wainberg MA (2002) Genetic diversity of human immunodeficiency virus type 1 Ethiopian clade C reverse transcriptase (RT) and rapid development of resistance against nonnucleoside inhibitors of RT. Antimicrobial Agents & Chemotherapy 46:2087-2094.
9. Moore CB, John M, James IR, Christiansen FT, Witt CS & Mallal SA (2002) Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 296:1439-1443.
10. Ogg GS, Jin X, Bonhoeffer S, Dunbar PR, Nowak MA, Monard S, Segal JP, Cao Y, Rowland-Jones SL, Cerundolo V, Hurley A, Markowitz M, Ho DD, Nixon DF & McMichael AJ (1998) Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279:2103-2106.
11. Preston BD & Dougherty JP (1996) Mechanisms of retroviral mutation. Trends in Microbiology 4:16-21.
12. Quinones-Mateu M, Weber J, Rangel H & Charkaborty B (2001) HIV-1 fitness and antiretroviral drug resistance. AIDS Reviews 3:223-242.
13. Rezende LF, Drosopoulos WC & Prasad VR (1998) The influence of the 3TC resistance mutation M184I on the fidelity and error specificity of human immunodeficiency virus type 1 reverse transcriptase. Nucleic Acids Research 26:3066-3072.
14. Roberts J, Bebenek K & Kunkel T (1998) The accuracy of reverse transcriptase from HIV-1. Science 242:1171-1173.
15. Salomon H, Wainberg MA, Brenner B, Quan Y, Rouleau D, Cote P, LeBlanc R, Lefebvre E, Spira B, Tsoukas C, Sekaly RP, Conway B, Mayers D & Routy JP (2000) Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use. Investigators of the Quebec Primary Infection Study. AIDS 14:F17-23.
16. Samri A, Haas G, Duntze J, Bouley JM, Calvez V, Katlama C & Autran B (2000) Immunogenicity of mutations induced by nucleoside reverse transcriptase inhibitors for human immunodeficiency virus type 1-specific cytotoxic T cells. Journal of Virology 74:9306-9312.
17. Schmitt M, Harrer E, Goldwich A, Bauerle M, Graedner I, Kalden JR & Harrer T (2000) Specific recognition of lamivudine-resistant HIV-1 by cytotoxic T lymphocytes. AIDS 4:653-658.
18. Shankarappa R, Margolick JB, Gange SJ, Rodrigo AG, Upchurch D, Farzadegan H, Gupta P, Rinaldo CR, Learn GH, He X, Huang XL & Mullins JI (1999) Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infecuon. Journal of Virology 73:10489-10502.
19. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F & Higging DG (1997) The Clustal X windows interface: flexible strategies of multiple sequence alignment aided by qualify analysis tools. Nucleic Acids Research 25:4876-4882.
20. Turner D, Brenner B, Moisi D, Detorio M, Cesaire R, Kurimura K, Mori H, Essex M, Maayan S & Wainberg MA (2004) Nucleotide and amino acid polymorphisms at drug resistance sites in non-B subtype variants of human immunodeficiency virus type 1. Antimicrobial Agents & Chemotherapy 48:2993-2998.
21. Turner D, Brenner B, Routy J-P, Moisi D, Rosberger Z, Roger M & Wainberg M-A (2004) Diminished representation of HIV-1 variants containing select drug resistance-conferring mutations in primary HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes (in press).
22. Wainberg MA, Drosopoulos WC, Salomon H, Hsu M, Borkow G, Parniak M, Gu Z, Song Q, Manne J, Islam S, Castriota G & Prasad VR (1996) Enhanced fidelity of 3TC-selected mutant HIV-1 reverse transcriptase. Science 271:2282-2288.